Catheter Precision closes $3.47M Series C-2 preferred; issues $11M Series D for Flyte acquisition

Catheter Precision, Inc.

3,470 shares of Series C-2 Preferred at $1,000 stated value sold for gross proceeds of $3,470,000.
11,028 shares of Series D Preferred ($11.03M stated value) issued to SEG Jets and Creatd for Fly Flyte acquisition.
Series C-2 conversion price $0.883/share, floor $0.35; Series D conversion price $1.1038/share, subject to reduction.
Stockholder approval obtained April 15, 2026; proceeds for working capital and general corporate purposes.
Beneficial ownership limitation initially 4.99%, can be increased to 9.99% on 61 days' notice.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Catheter Precision, Inc. issued 3,470 shares of preferred stock to the purchasers signatory thereto for aggregate gross proceeds of $3,470,000.

Security: preferred stock
Shares: 3,470 shares
Purchaser: the purchasers signatory thereto
Consideration: aggregate gross proceeds of $3,470,000

Exact text from the filing

Issuance of Series C-2 Convertible Preferred Stock On April 21, 2026, Catheter Precision, Inc. (the "Company") consummated the closing (the "Series C-2 Closing") of its previously disclosed sale and issuance of an aggregate of 3,470 shares of the Company's newly designated Series C-2 Convertible Preferred Stock, par value $0.0001 per share and stated value of $1,000 per share (the "Series C-2 Preferred Stock"), for aggregate gross proceeds of $3,470,000.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Catheter Precision, Inc.: Filed Series C-2 Certificate of Designation designating 3,470 shares as Series C-2 Convertible Preferred Stock and Series D Certificate of Designation designating 11,028 shares as Series D Convertible Preferred Stock (effective 2026-04-17).

Change: charter amendment
Effective: 2026-04-17

Exact text from the filing

On April 17, 2026, the Company filed each of the Series C-2 Certificate of Designation and the Series D Certificate of Designation with the Secretary of State of the State of Delaware.

View on SEC.gov

25 equity issuances filed in the last 30 days. Browse all equity issuances →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-013183

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.